Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italy: NHS facts and figures:

This article was originally published in Clinica

Executive Summary

There are 1,117 public hospitals in Italy with some 301,668 beds, according to a recent healthcare feature in Il Sole-24 Ore. Just over 600 private and non-profit hospitals are also contracted to carry out services on behalf of the national health service. Some 8.2 million patients are treated annually in hospital at an average cost of Lit 5.8 million ($3,500) each, accounting for a total of nearly 80 million patient days. The ratio of practising doctors to inhabitants is 1:187. A total of 73,601 doctors work in the hospital sector, although there is still a surplus of qualified doctors in the country. National healthcare service spending totalled Lit 91,619,000 million in 1994, Lit 19,218,000 of which was spent on goods and services. Private healthcare spending amounted to Lit 33,476,000 million.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091683

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel